Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Frakefamide is unable to penetrate the blood-brain-barrier and enter the central nervous system. Frakefamide TFA is a potent analgesic that acts as a peripheral active μ-selective receptor agonist.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Frakefamide is unable to penetrate the blood-brain-barrier and enter the central nervous system. Frakefamide TFA is a potent analgesic that acts as a peripheral active μ-selective receptor agonist. |
In vivo | Frakefamide yields a dose dependent increase in morphine appropriate responding to 50% at the highest dose tested (10 μmol/kg) after infusion durations of 2 min, whereas after 15 min infusions a maximum of 25% morphine appropriate responding was occasioned at 17.5 μmol/kg. |
Synonyms | Frakefamide TFA |
Molecular Weight | 677.64 |
Formula | C32H35F4N5O7 |
CAS No. | T11323 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Frakefamide TFA (188196-22-7 free base) T11323 Others 188196-22-7 free base 188196-22-7 Frakefamide TFA Frakefamide TFA (188196 22 7 free base) Frakefamide TFA (188196227 free base) inhibitor inhibit